×

Kite CEO: May see cancer drug approval by end of year

2:17 PM ET Tue, 28 Feb 2017

CNBC's Meg Tirrell and Arie Belldegrun, CEO of Kite Pharmaceuticals, discuss what's behind the company's big stock day.